Now the persons suffering from any disease can hope for this special treatment which involve no drug, no transplantation, no other therapy but only reprogrammed stem cells inside the body. This is what is called as breakthrough in the regenerative medicine field.

This discovery was done by the Harvard biologists during a series of painstaking experiments involving mice. It is when they found that three crucial molecular switches that, when flipped, completely convert a common cell in the pancreas into the more precious insulin-producing cells. This discovery was a major news as this will help the diabetics to recover soon by producing insulin which they need to take from outside to survive.

They also found that through this treatment not only diabetes but also other diseases like heart disease, strokes and many other ailments can be cured and that can be done by only getting their cells reprogrammed. These reprogrammed cells have so much power that they can cure the disease without the the need of drugs, transplants or other therapies but only by developing the cells which act as a cure inside the body. And so the scientists believes that this will change the face of regenerative medicine.

As if now the discovery is successful in mice but soon we are going to start the experiment with the persons. And we hope the same positive result from that experiment too as the pancreatic development of mice and humans are very closely related, says said George Q. Daley, a stem cell researcher at Children’s Hospital in Boston.

Douglas A. Melton, co-director of the Harvard Stem Cell Institute, who lead the research says that, it is like an extreme makeover of a cell. This will help in creating cells that are missing or defective in people suffering from any disease. It is kind of exciting.

Robert Lanza, chief scientific officer of Advanced Cell Technology in Worcester, Mass., a developer of stem cell therapy on listening the news says, I’m stunned through the discovery. This new information will introduces a whole new paradigm for treating disease.

Although they are also worried about the situation that has forced the researchers to stop the research as the critics say that this development involving the embryonic stem cells is done by destroying the embryos.

“I see no moral problem in this basic technique,” said Richard Doerflinger of the U.S. Conference of Catholic Bishops, a leading opponent of embryonic stems cell research. “This is a ‘win-win’ situation for medicine and ethics.”